PUBLISHER: The Business Research Company | PRODUCT CODE: 1669473
PUBLISHER: The Business Research Company | PRODUCT CODE: 1669473
Cellulite treatment encompasses a range of methods and procedures designed to reduce the visible effects of cellulite, characterized by a dimpled or lumpy texture often found on the skin, especially in areas such as the thighs, buttocks, and abdomen. These treatments aim to enhance the aesthetic appearance of the skin affected by cellulite.
The primary procedures for cellulite treatment fall into three categories such as non-invasive, minimally invasive, and topical. Non-invasive procedures involve medical or cosmetic treatments that don't require the insertion of instruments, devices, or substances into the body or the use of surgical incisions. These procedures are effective in addressing various types of cellulitis, including soft, hard, and edematous cellulitis. End users for cellulite treatment include hospitals, cosmetic surgery centers, and specialized dermatology clinics.
The cellulite treatment market research report is one of a series of new reports from The Business Research Company that provides cellulite treatment market statistics, including cellulite treatment industry global market size, regional shares, competitors with a cellulite treatment market share, detailed cellulite treatment market segments, market trends and opportunities, and any further data you may need to thrive in the cellulite treatment industry. This cellulite treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cellulite treatment market size has grown rapidly in recent years. It will grow from $2.26 billion in 2024 to $2.52 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to beauty and aesthetic concerns, increasing disposable income, media influence and advertising, aging population, growing fitness and wellness culture
The cellulite treatment market size is expected to see rapid growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in non-invasive treatments, rising demand for minimally invasive procedures, personalized and combination therapies, global increase in cosmetic procedures, influence of wellness tourism. Major trends in the forecast period include focus on long-term results, telemedicine consultations for treatment planning, social media influencer partnerships, at-home cellulite treatment devices, educational campaigns on realistic expectations.
The cellulite treatment market is anticipated to experience significant growth, driven by the escalating cases of obesity. Obesity, a medical condition characterized by an excessive accumulation of body fat that poses health risks, contributes to increased cellulite formation. As obesity levels rise and fat accumulates for extended periods, it exerts pressure on lymphatic vessels, leading to tissue breakdown and the development of cellulitis. For instance, as per the World Obesity Atlas 2022 report in March 2022, the global estimate of individuals with obesity (Class I, II, and III) >=30kg/m2 was 764 million in 2020, projected to surge to 892 million by 2025. Consequently, the surging cases of obesity are acting as a catalyst for the growth of the cellulite treatment market.
The burgeoning demand for aesthetic and cosmetic procedures is also expected to propel the cellulite treatment market in the forthcoming years. Aesthetic and cosmetic procedures encompass surgical or medical interventions performed to enhance an individual's appearance for non-medical reasons, distinct from treatments aimed at addressing illnesses or physiological functions. Cellulite treatment is frequently sought in cosmetic procedures to improve the appearance of dimpled or lumpy skin, commonly found on the thighs, buttocks, hips, and abdomen. For example, based on a survey conducted by the International Society of Aesthetic Plastic Surgery in September 2023, the number of procedures performed by plastic surgeons witnessed an 11.2% increase in 2022, totaling approximately 14.9 million surgical and 18.8 million non-surgical procedures. This substantial surge in demand for aesthetic and cosmetic procedures is a pivotal driving force behind the growth of the cellulite treatment market.
The cellulite treatment market is witnessing a prominent trend centered on product innovation, with major companies actively introducing groundbreaking products to maintain their market standing. For instance, in March 2022, Endo International PLC, an Ireland-based pharmaceuticals company, unveiled Qwo (collagenase clostridium histolyticum-aaes), the first FDA-approved injectable treatment designed to address moderate to severe cellulite. QWO is hypothesized to enzymatically release fibrous septae, primarily targeting Types 1 and 3 collagen upon injection into the treatment area. This enzymatic action aims to enhance skin smoothness and improve the appearance of cellulite.
Leading companies in the cellulite treatment market are prioritizing approvals for innovative technologies, such as the Cellution device, to meet various critical industry demands. The Cellution device is designed to harvest, process, and prepare a patient's own cells for regenerative treatments, including fat grafting and stem cell therapy. For example, in May 2024, DELEO, a France-based manufacturing company, launched the Cellution device in the UK, presenting a groundbreaking non-invasive solution for cellulite treatment. Unveiled at a London event on April 25, 2024, Cellution integrates four advanced technologies-high-intensity focused diodes (HIFD(TM)), mechanical massage, active dermo-cosmetic ingredients, and radial vibration waves-providing a comprehensive approach to addressing cellulite. The device has received accolades for its safety and efficacy from industry experts, such as Dr. Rita Rakus. Cellution will be offered at select aesthetic clinics throughout the UK, with the goal of enhancing self-confidence and assisting patients in achieving their body goals through innovative treatments.
In February 2022, Sinclair Pharma, a UK-based pharmaceutical company, acquired Viora for an undisclosed amount. This acquisition is a strategic initiative aimed at enhancing Sinclair Pharma's Energy-Based Devices portfolio and solidifying its presence in the U.S. Viora is a U.S.-based medical aesthetic company that offers a non-invasive medical device utilizing radiofrequency energy and vacuum therapy to treat skin and fat.
Major companies operating in the cellulite treatment market include Hologic Inc., Merz Pharma GmbH & Co. KGaA, Lumenis Ltd, Cynosure Inc., ZELTIQ Aesthetics, BTL Industries Inc., Cutera Inc., Cytek Biosciences, Candela Corporation, Zimmer Aesthetics, Venus Concept, Solta Medical, LPG Systems, Fotona d.o.o., Viora Ltd., SharpLight Technologies Inc., Alma Lasers Ltd., Beijing Nubway S&T Co Ltd, Ellipse A/S, Lynton Lasers Ltd., EndyMed Medical Ltd., VIP Italia, Cellfina, Pollogen Ltd, Endo Systems LLC, Cosmetic Laser Solutions MedSpa, LipoTherapeia, Tanceuticals LLC, Synergy MedAesthetics, Asclepion Laser Technologies GmbH
North America was the largest region in the cellulite treatment market in 2024. The regions covered in the cellulite treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cellulite treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cellulite treatment market consists of revenues earned by entities by providing services such as laser treatment, radiofrequency therapy, and massage therapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cellulite treatment market also includes the sales of topical creams and cellulite reduction devices, which provide cellulite treatment services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cellulite Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cellulite treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cellulite treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cellulite treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.